Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$27,000.00
Investigating the Role of Messenger Ribonucleic Acid Quality Control Mechanisms in Cancer
FY 2024-25
Summary
The central dogma of molecular biology is that deoxyribonucleic acid (DNA) is transcribed into ribonucleic acid (RNA) then translated into protein. Throughout this process, there are several mechanisms in place to ensure that the proteins will be functional, including eliminating transcripts that contain detrimental mutations. My project will focus on mRNA quality control and how it relates to the progression of cancer. Genetic instability is inherent in cancer, leading to the accumulation of mutations within these cells. In theory, the immune system can recognise these mutations through a complex of proteins on the surface of the cell called major histocompatibility complex I (MHC I), which displays portions of the proteins that are produced in the cell to T cells. If a T cell detects a mutation in the protein fragments, it will kill this cell, but another characteristic of cancer is that it can evade detection by the immune system. However, if mRNA quality control pathways are disrupted, more mutated proteins will be displayed, making cancer cells more visible to the immune system via MHC I.As part of my project, I will characterise the effects of inhibiting mRNA quality control on cancer progression through silencing pivotal genes and observing changes in cell viability and stress markers. I will also analyse the changes that occur in MHC I when mRNA quality control is disrupted through analysing the amount and types of protein fragments displayed, as well as the ability of T cells to recognise these fragments as abnormal and trigger the death of the cell creating them. Additionally, I will carry out a multiplex imaging analysis of tissue samples from cancer patients to identify correlations between changes in mRNA quality control pathways and disease progression.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530366
Name
Peters Dana
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Role of Messenger Ribonucleic Acid Quality Control Mechanisms in Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antigen Presentation; Cancer; Immunopeptidome; Immunotherapy; Major Histocompatibility Complex I (Mhc I); Mrna Quality Control; Multiplex Imaging; Proteostasis
Abstract
The central dogma of molecular biology is that deoxyribonucleic acid (DNA) is transcribed into ribonucleic acid (RNA) then translated into protein. Throughout this process, there are several mechanisms in place to ensure that the proteins will be functional, including eliminating transcripts that contain detrimental mutations. My project will focus on mRNA quality control and how it relates to the progression of cancer. Genetic instability is inherent in cancer, leading to the accumulation of mutations within these cells. In theory, the immune system can recognise these mutations through a complex of proteins on the surface of the cell called major histocompatibility complex I (MHC I), which displays portions of the proteins that are produced in the cell to T cells. If a T cell detects a mutation in the protein fragments, it will kill this cell, but another characteristic of cancer is that it can evade detection by the immune system. However, if mRNA quality control pathways are disrupted, more mutated proteins will be displayed, making cancer cells more visible to the immune system via MHC I.As part of my project, I will characterise the effects of inhibiting mRNA quality control on cancer progression through silencing pivotal genes and observing changes in cell viability and stress markers. I will also analyse the changes that occur in MHC I when mRNA quality control is disrupted through analysing the amount and types of protein fragments displayed, as well as the ability of T cells to recognise these fragments as abnormal and trigger the death of the cell creating them. Additionally, I will carry out a multiplex imaging analysis of tissue samples from cancer patients to identify correlations between changes in mRNA quality control pathways and disease progression.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Peters, Dana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~